Medical Supplies for Pandemics Act of 2021

To amend the Public Health Service Act to authorize the use of the Strategic National Stockpile to enhance domestic medical supply chain elasticity and establish and maintain domestic reserves of critical medical supplies, and for other purposes. 1. Short title This Act may be cited as the Medical Supplies for Pandemics Act of 2021 2. Supply chain flexibility manufacturing pilot (a) In general Section 319F–2(a)(3) of the Public Health Service Act (42 U.S.C. 247d–6b(a)(3)) is amended— (1) in subparagraph (I), by striking and (2) in subparagraph (J), by striking the period at the end and inserting ; and (3) by adding at the end the following new subparagraph: (K) enhance domestic medical supply chain elasticity and establish and maintain domestic reserves of critical medical supplies (including personal protective equipment, ancillary medical supplies, testing supplies, and other applicable supplies required for the administration of drugs, vaccines and other biological products, medical devices, and diagnostic tests) by— (i) creating incentives for the domestic manufacturing of medical supplies— (I) to increase emergency stock of critical medical supplies; and (II) to geographically diversify production of such supplies; (ii) purchasing, leasing, or entering into joint industrial-based expansion ventures with respect to, facilities and equipment for the production of medical supplies; and (iii) working with distributors of medical supplies to manage the domestic reserves established under this subparagraph by refreshing and replenishing stock of critical medical supplies. . (b) Reporting; sunset Section 319F–2(a) of the Public Health Service Act (42 U.S.C. 247d–6b(a)) is amended by adding at the end the following: (6) Reporting Not later than September 30, 2022, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on the details of each purchase, lease, or joint industrial-based expansion venture entered into under paragraph (3)(K), including the amount expended by the Secretary on each such purchase, lease, or joint venture. (7) Sunset The authority to make purchases, leases, or joint ventures pursuant to paragraph (3)(K) shall cease to be effective on September 30, 2024. . (c) Funding Section 319F–2(f) of the Public Health Service Act (42 U.S.C. 247d–6b(f)) is amended by adding at the end the following: (3) Supply chain elasticity (A) In general For the purpose of carrying out subsection (a)(3)(K), there is authorized to be appropriated $500,000,000 for each of fiscal years 2021 through 2024, to remain available until expended. (B) Relation to other amounts The amount authorized to be appropriated by subparagraph (A) for the purpose of carrying out subsection (a)(3)(K) is in addition to any other amounts available for such purpose. .

Summary: Medical Supplies for Pandemics Act of 2021 This bill requires the Department of Health and Human Services (HHS) to take specified actions, as part of its management of the Strategic National Stockpile, to establish and maintain domestic reserves of critical medical supplies. Specifically, HHS must (1) create incentives for domestic manufacturers of medical supplies to increase emergency stocks and diversify geographic production; (2) purchase, lease, or enter into joint ventures with respect to facilities and equipment to produce medical supplies; and (3) work with distributors to refresh and replenish medical supplies. HHS must also submit a report to Congress concerning the details of any purchase, lease, or joint venture. The department's authority under the bill to make purchases, leases, or joint ventures for medical supplies terminates on September 30, 2024.